Evidence map›Paper›PMID 32146647›Full record

ReviewNeurochemical research2020

In Situ Regulated Dopamine Transporter Trafficking: There's No Place Like Home.

Rita R Fagan, Patrick J Kearney, Haley E Melikian

Open access · greenAbstract readReview
In one paragraph

Review in Neurochemical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Substance abuse and neurotransmission.Advances in pharmacology (San Diego, Calif.) · 2022
    Article
  9. Article
  10. Article
  11. Methamphetamine Dysregulation of the Central Nervous System and Peripheral Immunity.The Journal of pharmacology and experimental therapeutics · 2021
    Review
  12. Review
  13. Review
  14. Review
  15. Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rita R FaganBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Patrick J KearneyBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, University of Massachusetts Medical School, Worcester, MA, 01605, USA.
Haley E MelikianBrudnick Neuropsychiatric Research Institute, Department of Neurobiology, University of Massachusetts Medical School, Worcester, MA, 01605, USA. haley.melikian@umassmed.edu.
Neuropsychiatric Research Institute · US

Funding

Trafficking and Regulation of Monoamine TransportersR01DA015169 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELIKIAN, HALEY E · 2002 to 2017
$5.2M
Dopamine Transporter Cell Surface DynamicsR01DA035224 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MELIKIAN, HALEY E · 2013 to 2022
$4.3M
Gq Receptor Regulation Of Striatal Dopamine TransportersF31DA045446 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KEARNEY, PATRICK JOSEPH · 2019 to 2020
$65k
NIDA NIH HHS DA035224NIDA NIH HHS F31 DA045446-A1NIDA NIH HHS R01 DA015169NIDA NIH HHS R01 DA035224
6 · The paper itself

Abstract

Dopamine (DA) is critical for motivation, reward, movement initiation, and learning. Mechanisms that control DA signaling have a profound impact on these important behaviors, and additionally play a role in DA-related neuropathologies. The presynaptic SLC6 DA transporter (DAT) limits extracellular DA levels by clearing released DA, and is potently inhibited by addictive and therapeutic psychostimulants. Decades of evidence support that the DAT is subject to acute regulation by a number of signaling pathways, and that endocytic trafficking strongly regulates DAT availability and function. DAT trafficking studies have been performed in a variety of model systems, including both in vitro and ex vivo preparations. In this review, we focus on the breadth of DAT trafficking studies, with specific attention to, and comparison of, how context may influence DAT's response to different stimuli. In particular, this overview highlights that stimulated DAT trafficking not only differs between in vitro and ex vivo environments, but also is influenced by both sex and anatomical subregions.

Indexed as

AnimalsBrainDopamineDopamine Plasma Membrane Transport ProteinsGABA Plasma Membrane Transport ProteinsHumansProtein TransportSignal TransductionDopamineDopamine Plasma Membrane Transport ProteinsGABA Plasma Membrane Transport ProteinsSLC6A1 protein, humanDopamine transporterMembrane traffickingStriatum

Identifiers

PMID32146647
PMCPMC7261626
OpenAlexW3009551351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.